University of Toronto study reinterprets Crohn's disease origins

Researchers at the University of Toronto have published a study in the journal ‘Nature Immunology’ that may redefine the understanding of Crohn’s disease. The findings suggest that the onset of the disease may be linked to a weakened immune response to infection rather than the traditionally held belief of an overactive immune system.

Led by Dr. Dana Philpott, the study examined T-cell responses in animal models with variations of the NOD2 gene, which is linked to increased Crohn’s risk. The research indicates that defects in the NOD2 gene can limit the ability of T-cells to reach intestinal lymph nodes, thereby weakening the early immune response and reducing the body's efficiency in managing infections. When the NOD2 gene fails to function correctly, the intestinal barrier may become more permeable, allowing more microbes to enter body tissues.

Researcher Boyan Tsankov noted that this impaired function may prevent the body from efficiently clearing intestinal infections, eventually prompting the immune system to ramp up its response over time, which contributes to the chronic inflammation characteristic of the disease. These findings could lead to new therapeutic approaches that target the underlying immune deficiency rather than solely focusing on controlling inflammation.